Loading…
Pharvaris N.V.
Pharvaris N.V. (PHVS) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Zug, Switzerland and has 148 employees. The company is worth $2.15B. Revenue was €0 in fiscal 2025. It reported a net loss of €175.7M. The share price is 29.1% below its 52-week high of $43.25. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Andreas Halvorsen (Viking Global Investors), at $126.33M. In that quarter, 4 of them opened or added to the position. Over the last 30 days, company insiders sold $395.52K of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in EUR, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +88.6% over 5Y.
today you would have $1,591.51▲ +59.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $27.75 | $19.17 | $28.05 | $11.25 | |
| EPS | -€2.97 | -€2.48 | -€2.63 | -€2.27 | |
| ROE | -50.63% | -64.77% | -50.13% | -26.27% | -51.14% |
This company reports in EUR, and the stock trades in dollars. P/E, P/S, P/B and payout would divide dollars by EUR, so they are not shown; EPS is in EUR. Margin, ROE and dividend yield do not depend on the currency.
Median of the years shown; P/E years above 200x are left out.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| IMNMImmunome Inc. | $18.26 | — | 3.9x | 0.00% | -64.03% | $2.15B |
| AXGNAxogen, Inc. | $36.68 | — | 7.7x | 0.00% | -18.21% | $2.15B |
| VCELVericel Corp | $42.97 | 91.4x | 5.9x | 0.00% | 7.16% | $2.2B |
| NEONeogenomics Inc | $16.39 |
| — |
| 2.7x |
| 0.00% |
| -6.33% |
| $2.11B |
| INSPInspire Medical Systems, Inc. | $72.66 | 16.0x | 2.5x | 0.00% | 17.96% | $2.1B |
| HRMYHarmony Biosciences Holdings, Inc. | $36.03 | 12.3x | 2.1x | 0.00% | 20.46% | $2.1B |